REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Innocare Pharma Limited (China)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Innocare Pharma Limited Profile Updated: December 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

InnoCare Pharma Limited is committed to discovering, developing and commercializing best-in-class and/or first-in-class drugs for the treatment of cancer and autoimmune diseases. The company’s main products include drugs for the treatment of cancer and autoimmune diseases. The company was established in 2015 and is headquartered in Beijing City, China.

Headquarters
Building 8, Yard 8, Life Garden Road, Zhongguancun Life Science Park, Changping District, Beijing
Beijing; Beijing; Postal Code: 102206

Contact Details: Purchase the Innocare Pharma Limited report to view the information.

Website: http://www.innocarepharma.com

Basic Information
Total Employees:
Purchase the Innocare Pharma Limited report to view the information.
Outstanding Shares:
Purchase the Innocare Pharma Limited report to view the information.
Registered Capital:
Purchase the Innocare Pharma Limited report to view the information.
Financial Auditors:
Purchase the Innocare Pharma Limited report to view the information.
Incorporation Date:
November 03, 2015
Key Executives
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Executive Director
Purchase this report to view the information.
Chief Financial Officer
Ownership Details
Purchase this report to view the information.
41.32%
Purchase this report to view the information.
11.83%
Purchase this report to view the information.
9.01%
Purchase this report to view the information.
8.2%
Purchase this report to view the information.
7.42%
Subsidiaries
Beijing Nuocheng Jianhua Pharmaceutical Technology Co., Ltd.
100%
InnoCare Pharma Australia Pty Ltd
100%
InnoCare Pharma Inc.
100%
Company Performance
Financial values in the chart are available after Innocare Pharma Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
29.85%▲
Total operating revenue
31.56%▲
Operating profit (EBIT)
48.02%▲
Net Profit (Loss) for the Period
47.09%▲
Total assets
-5.8%▼
Total equity
-7.56%▼
Operating Profit Margin (ROS)
61.25%▲
Net Profit Margin
59.47%▲
Return on Equity (ROE)
3.13%▲
Debt to Equity Ratio
16.12%▲
Quick Ratio
3.29%▲
Cash Ratio
2.65%▲

Similar companies

Sinopharm Group Company Limited
 
Shanghai Pharmaceuticals Holding Co.,Ltd
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
 
Nanjing Pharmaceutical Company Limited
Chongqing Zhifei Biological Products Co.,Ltd.
 
Hubei Biocause Pharmaceutical Co.,Ltd.
Shanghai Fudan Forward S&T Co., Ltd.
 
Ys Biopharma Co. Ltd.
Chongqing Pharscin Pharmaceutical Co., Ltd.
 
Hunan Jingfeng Pharmaceutical Co.,Ltd.
HBM Holdings Limited
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo